Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Results
Phase 3
This trial was for people with non small cell lung cancer (NSCLC) that had spread to another part of the body.
This trial was open for people to join between August 2015 and November 2016.
These results were published in 2018.
Recruitment start: 1 August 2015
Recruitment end: 15 August 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Spicer
Bristol-Myers Squibb
Experimental Cancer Medicine Centre (ECMC)
Ono Pharmaceutical Co. Ltd
Last reviewed: 8 July 2019
CRUK internal database number: 14094